1. Home
  2. NVCT vs DUOT Comparison

NVCT vs DUOT Comparison

Compare NVCT & DUOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NVCT
  • DUOT
  • Stock Information
  • Founded
  • NVCT 2020
  • DUOT 1990
  • Country
  • NVCT United States
  • DUOT United States
  • Employees
  • NVCT N/A
  • DUOT N/A
  • Industry
  • NVCT Medicinal Chemicals and Botanical Products
  • DUOT Computer Software: Prepackaged Software
  • Sector
  • NVCT Health Care
  • DUOT Technology
  • Exchange
  • NVCT Nasdaq
  • DUOT Nasdaq
  • Market Cap
  • NVCT 167.0M
  • DUOT 180.1M
  • IPO Year
  • NVCT 2022
  • DUOT N/A
  • Fundamental
  • Price
  • NVCT $6.03
  • DUOT $8.76
  • Analyst Decision
  • NVCT Strong Buy
  • DUOT Strong Buy
  • Analyst Count
  • NVCT 3
  • DUOT 2
  • Target Price
  • NVCT $15.33
  • DUOT $12.75
  • AVG Volume (30 Days)
  • NVCT 109.6K
  • DUOT 374.1K
  • Earning Date
  • NVCT 11-04-2025
  • DUOT 11-12-2025
  • Dividend Yield
  • NVCT N/A
  • DUOT N/A
  • EPS Growth
  • NVCT N/A
  • DUOT N/A
  • EPS
  • NVCT N/A
  • DUOT N/A
  • Revenue
  • NVCT N/A
  • DUOT $19,026,308.00
  • Revenue This Year
  • NVCT N/A
  • DUOT $292.26
  • Revenue Next Year
  • NVCT N/A
  • DUOT $43.21
  • P/E Ratio
  • NVCT N/A
  • DUOT N/A
  • Revenue Growth
  • NVCT N/A
  • DUOT 159.00
  • 52 Week Low
  • NVCT $4.44
  • DUOT $3.84
  • 52 Week High
  • NVCT $11.52
  • DUOT $11.23
  • Technical
  • Relative Strength Index (RSI)
  • NVCT 49.43
  • DUOT 48.49
  • Support Level
  • NVCT $5.86
  • DUOT $8.00
  • Resistance Level
  • NVCT $6.24
  • DUOT $9.53
  • Average True Range (ATR)
  • NVCT 0.33
  • DUOT 0.87
  • MACD
  • NVCT -0.00
  • DUOT -0.20
  • Stochastic Oscillator
  • NVCT 61.76
  • DUOT 27.09

About NVCT Nuvectis Pharma Inc.

Nuvectis Pharma Inc is a biopharmaceutical company. The company is engaged in the development of innovative precision medicines for the treatment of serious conditions of unmet medical needs in oncology. It operates with one segment, focused on the development of novel targeted small molecule therapeutics for the treatment of cancer in genetically defined patient populations. Its pipeline products include NXP800, NXP900.

About DUOT Duos Technologies Group Inc.

Duos Technologies Group Inc operating under its brand name duostech, designs, develops, deploys and operates intelligent technology solutions supporting rail, logistics and intermodal businesses that streamline operations, improve safety and reduce costs. The company's main offering, the Railcar Inspection Portal (RIP), provides both freight and transit railroad customers and select government agencies the ability to conduct fully automated railcar inspections of trains that are moving at full speed. It has also developed the Automated Logistics Information System (ALIS) which automates gatehouse operations where transport trucks enter and exit large logistics and intermodal facilities. Its segments are Rail, Commercial, Governments, Banking and AI.

Share on Social Networks: